---
document_datetime: 2023-09-21 19:43:53
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sevelamer-carbonate-winthrop-epar-all-authorised-presentations_en.pdf
document_name: sevelamer-carbonate-winthrop-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.989356
conversion_datetime: 2025-12-22 16:38:30.121603
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/14/952/001   | Sevelamer carbonate Winthrop   | 800 mg   | Film-coated tablet         | Oral use   | bottle (HDPE)             | 180 tablets                      |
|-------------------|--------------------------------|----------|----------------------------|------------|---------------------------|----------------------------------|
| EU/1/14/952/002   | Sevelamer carbonate Winthrop   | 2.4 g    | Powder for oral suspension | Oral use   | sachet (EAA/PET/LDPE/alu) | 60 sachets                       |
| EU/1/14/952/003   | Sevelamer carbonate Winthrop   | 2.4 g    | Powder for oral suspension | Oral use   | sachet (EAA/PET/LDPE/alu) | 90 sachets                       |
| EU/1/14/952/004   | Sevelamer carbonate Winthrop   | 800 mg   | Film-coated tablet         | Oral use   | bottle (HDPE)             | 30 tablets                       |
| EU/1/14/952/005   | Sevelamer carbonate Winthrop   | 0.8 g    | Powder for oral suspension | Oral use   | sachet (EAA/PET/LDPE/alu) | 90 sachets                       |
| EU/1/14/952/006   | Sevelamer carbonate Winthrop   | 0.8 g    | Powder for oral suspension | Oral use   | sachet (EAA/PET/LDPE/alu) | 90 sachets (with a dosing spoon) |